Pemazyre Alternatives Compared
Pemazyre | Pemigatinib | Futibatinib |
|
---|
Pemazyre (pemigatinib) | Pemigatinib | Futibatinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Myeloid/Lymphoid Neoplasms, Cholangiocarcinoma. Pemazyre may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myeloid/Lymphoid Neoplasms, Cholangiocarcinoma. pemigatinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cholangiocarcinoma. futibatinib may also be used for purposes not listed in this medication guide. |
Related suggestions Cholangiocarcinoma
|
|||||||
More about Pemazyre (pemigatinib) | More about Pemigatinib | More about Futibatinib | ||||||||
Ratings & Reviews | ||||||||||
Pemazyre has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Pemigatinib has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Pemazyre side effects in more detail. |
See also: pemigatinib side effects in more detail. |
See also: futibatinib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Pemazyre prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
|
N/A |
N/A |
||||||||
Brand Names | ||||||||||
N/A |
Pemazyre | Lytgobi | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
15.4 hours |
15.4 hours |
2.9 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 263 drugs are known to interact with Pemazyre:
|
A total of 263 drugs are known to interact with pemigatinib:
|
A total of 151 drugs are known to interact with futibatinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
April 17, 2020 |
April 17, 2020 |
September 30, 2022 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.